Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment
DOI:
10.1016/j.ejca.2021.02.031
Publication Date:
2021-04-06T00:17:02Z
AUTHORS (28)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (31)
CITATIONS (19)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....